Eloxx Pharmaceuticals, Inc. (ELOX) Balance sheet

Market cap

$92.56M

P/E ratio

	2013/06	2014/06	2015/06	2016/06	2017/06	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2025/12
Cash and cash equivalents	2	6	3	810,808	33,198	24	49	22	25	42	19	5
Total cash & short-term investments	2	6	3	810,808	33,198	24	49	22	25	42	19	5
Accounts receivable, net	-	43,133	-	-	-	-	-	-	-	-	-	-
Total current assets	4	7	4	982,628	284,421	25	50	58	26	43	20	5
Property, plant and equipment, net	4,555	223,475	185,948	92,554	50,979	0	0	0	0	0	0	-
Total assets	7	33	20	9	6	25	51	59	26	45	21	5
Accounts payable	637,320	901,180	232,033	90,305	191,597	2	1	2	0	1	3	3
Long-term debt, current	-	-	-	-	-	-	-	4	5	-	4	1
Total current liabilities	3	2	778,516	368,991	3	3	8	12	10	10	23	17
Long-term debt, non-current	-	-	-	-	-	-	-	11	6	12	9	-
Total liabilities	3	6	7	5	5	-	-	23	16	23	32	17
Retained earnings	-	-	-	-115,630,059	-121,824,326	-39	-86	-137	-172	-238	-274	-301
Stockholders' equity	4	27	12	5	871,206	21	43	36	10	22	-11	-12